Hot off the press! Our experience in providing HCV meds in-hand to postpartum women at discharge from hospital admissions for labor and delivery. Meds to beds = higher HCV treatment completion than a traditional linkage to outpatient care-based approach. journals.lww.com/ogopen/fullt...

@madelinemc5.bsky.social and I are excited to share that our HCV rapid start program at WashU ID has delivered over 200 courses of HCV meds to the bedside for inpatients at BJH! This allows people to start HCV rx at discharge, just like they would for any other new med prescribed on discharge.

With the publication of PURPOSE 2 for PrEP in @nejm.org, and the stellar results, I wonder what’s going to happen once it gets approved for this indication. Should be interesting, to say the least! blogs.jwatch.org/hiv-id-obser...

Re-infection and resistance associated substitutions following a minimal monitoring approach for HCV treatment in MINMON trial ✅ Just Accepted #IDsky

Long-term 4CMenB vaccine effectiveness against gonococcal infection at four years post program implementation: observational case-control study ✅ Just Accepted #IDSKy

A superb collection of free, practical guides and hands-on resources for authors looking to improve their scientific publishing skillset by @plos.bsky.social plos.org/resources/wr...

This is such important data! So glad to see it out in print! Being able to offer our pregnant patients biktarvy has been such a game-changer 🥰

Such a treat to open my OFID inbox this morning and see so many amazing papers by teams from across the globe on care of PWUD with infections. Hoping potential reviewers also feel the same way 😆🤩😆. Reviewer invites for all our #IDCircus friends forthcoming.